Lin C, Kwong AD, Perni RB (marzo de 2006). «Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease». Infect Disord Drug Targets6 (1): 3-16. PMID16787300. doi:10.2174/187152606776056706.
Lin C, Kwong AD, Perni RB (marzo de 2006). «Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease». Infect Disord Drug Targets6 (1): 3-16. PMID16787300. doi:10.2174/187152606776056706.